Results 81 to 90 of about 5,477 (176)

Assessment of soluble ST2 as a biomarker for cardiac remodeling in heart failure patients [PDF]

Al-Azhar International Medical Journal
Background: Heart failure with reduced ejection fraction (HFrEF) continues to be a worldwide health burden, with ongoing adverse cardiac remodeling. Soluble suppression of tumorigenicity-2 (sST2) is a biomarker associated with myocardial inflammation and
Ahmed Gaafar, Ahmed Sedeek, Magdy Farouk, Yasser Sadek   +3 more
doaj   +1 more source

The elevated levels of soluble growth stimulation expressed gene 2 are associated with coronary atherosclerotic plaque destabilization in unstable angina patients: a case control study

BMC Cardiovascular Disorders
Background Plaque destabilization and rupture are the primary triggers of acute coronary syndrome (ACS). Soluble growth stimulation expressed gene 2 (sST2) has been implicated in cardiovascular disease.
Ning Li, Xinjian Li, Lin Ni, Xuewen Li
doaj   +1 more source

The diagnostic and prognostic value of soluble ST2 in Sepsis

Frontiers in Medicine
ObjectiveTo determine the diagnostic and prognostic value of soluble suppression of tumorigenicity 2 (sST2) in patients with sepsis.MethodsA total of 113 critically ill patients were enrolled at the emergency department of Beijing Chaoyang Hospital Jing ...
Xinghua Ye, Jia Wang, Le Hu, Ying Zhang, Yixuan Li, Jingchao Xuan, Silu Han, Yifan Qu, Long Yang, Jun Yang, Junyu Wang, Bing Wei   +11 more
doaj   +1 more source

Diagnostic value of serum soluble suppression of tumorigenicity 2 in patients with heart failure in different types of heart diseases

Zhongguo linchuang yanjiu
Objective To observe the changes of soluble growth stimulation expression gene 2 (sST2) level in patients with heart failure in different types of heart diseases, and analyze the diagnostic value of sST2 in heart failure. Methods A total of 74 patients
XIA Li*, YIN Yi, ZHOU Dewei, WU Jiaming, WANG Hongzhi
doaj   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Associations of Soluble Serum Stimulation‐2 With Functional Outcomes and Death at 1 Year in Acute Ischemic Stroke: A Prospective Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Elevated sST2 (soluble serum stimulation‐2) has been associated with poor 90‐day outcomes of patients with acute ischemic stroke (AIS). We aimed to investigate the associations between baseline serum sST2 level and 1‐year outcomes in patients ...
Xuan Tian, Xiao Wang, Lulu Pei, Kai Liu, Yuan Gao, Yuming Xu, Xinyi Leng, Bo Song   +7 more
doaj   +1 more source

Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction

BMC Cardiovascular Disorders
Background Left ventricular thrombosis (LVT) after acute ST-segment elevation myocardial infarction (STEMI) is closely related to inflammation. Soluble Suppression of Tumorigenicity 2 (sST2) expressed as a novel inflammatory marker, has received much ...
Xinjia Du, Perkash Kumar, Chen Liu, Jiahua Liu, Lei Chen, Yuan Lu, Zhuoqi Zhang   +6 more
doaj   +1 more source

Issue Information

The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 6, June 2026.
wiley   +1 more source

Association between sST2 Levels and Cardiovascular Outcomes and Effect of Sacubitril/Valsartan on sST2 Levels: Results From the PARADIGM-HF Trial [PDF]

Journal of Cardiac Failure, 2016
Eileen O'Meara, Margaret F. Prescott, Jean L. Rouleau, Lu-May Chiang, Scott D. Solomon, Karl Swedberg, Milton Packer, John J.V. McMurray, Michael R. Zile   +8 more
openaire   +1 more source

Serum sST2 and MR-ProADM in pediatric acute rheumatic fever: association with cardiac involvement and clinical risk stratification. [PDF]

Front Pediatr
Altınok EI, Ertürk EY, Bayrak T, Yapar Gümüş C, Bayrak A, Kasar T.   +5 more
europepmc   +1 more source